Neurocrine Biosciences
NBIX
$179.90
Share price
-0.74%
Change (1 day)
-14.87%
Change (1 year)
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.
Neurocrine Biosciences (NBIX) - Cash on Hand
Cash on Hand as of December 2024 : A$1.71 Billion
According to Neurocrine Biosciences
's latest financial reports the company has A$1.71 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | A$1.73 B | 14.26% |
| 2023-12-31 | A$1.51 B | 4.15% |
| 2022-12-31 | A$1.45 B | 48.17% |
| 2021-12-31 | A$0.98 B | -5.82% |
| 2020-12-31 | A$1.04 B | 8.78% |
| 2019-12-31 | A$0.95 B | 3.65% |
| 2018-12-31 | A$0.92 B | 39.81% |
| 2017-12-31 | A$0.66 B | 54.99% |
| 2016-12-31 | A$0.42 B | -18.08% |
| 2015-12-31 | A$0.52 B | 119.8% |
| 2014-12-31 | A$0.23 B | 44.94% |
| 2013-12-31 | A$0.16 B | -1.86% |
| 2012-12-31 | A$0.16 B | 32.23% |
| 2011-12-31 | A$0.12 B | 0.81% |
| 2010-12-31 | A$0.12 B | 109.85% |
| 2009-12-31 | A$59.51 M | -47.82% |
| 2008-12-31 | A$0.11 B | -44.41% |
| 2007-12-31 | A$0.20 B | -11.42% |
| 2006-12-31 | A$0.23 B | -37.93% |
| 2005-12-31 | A$0.37 B | -4.09% |
| 2004-12-31 | A$0.38 B | -36.17% |
| 2003-12-31 | A$0.60 B | 40.37% |
| 2002-12-31 | A$0.43 B | -30.72% |
| 2001-12-31 | A$0.62 B | 112.88% |
| 2000-12-31 | A$0.29 B | 112.44% |
| 1999-12-31 | A$0.13 B | 625.53% |
| 1998-12-31 | A$19.1 M | -21.21% |
| 1997-12-31 | A$24.25 M | 70.49% |
| 1996-12-31 | A$14.22 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | A$1.20 B | -29.62% | 🇺🇸 USA |
 | A$2.81 B | 64.58% | 🇬🇧 UK |
 | A$5.43 M | -99.68% | 🇺🇸 USA |
 | A$5.44 B | 218.11% | 🇺🇸 USA |
 | A$8.83 B | 416.22% | 🇺🇸 USA |
 | A$32.55 B | 1,802.89% | 🇺🇸 USA |
 | A$0.24 B | -85.95% | 🇺🇸 USA |
 | A$1.62 M | -99.91% | 🇺🇸 USA |